Intuitive Surgical can meet or beat 2013 procedure outlook, says William Blair William Blair said its analysis and channel checks indicate Intuitive Surgical can meet or beat its 2013 procedure growth guidance of 20%-23% and sustain roughly 20% growth for the next several years. The firm recommends investors add to positions more aggressively on any pullbacks and keeps an Outperform rating on the stock.
Intuitive Surgical initiated with an Overweight, $575 target at Barclays Barclays analyst Matthew Taylor started shares of Intuitive Surgical with an Overweight rating and $575 price target. Taylor thinks surgery share will continue to shift to robotic and believes demand for Intuitive's da Vinci among general surgeons is very high. The stock closed yesterday down $4.17 to $492.45.